【レポートの概要(一部)】
1. Report Overview
1.1 Global Pharma Wholesale and Distribution Industry and Market Overview
1.2 Pharma Wholesale and Distribution Industry Structure
1.3 Benefits of This Report
1.4 How This Report Delivers
1.5 Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Pharma Wholesale and Distribution
2.1 The Role of Pharmaceutical Wholesalers: The Middlemen of the Pharmaceutical Industry
2.1.1 Full-Line Wholesalers (FLWs)
2.1.2 Short-Line Wholesalers (SLWs)
2.2 The Chain of Distribution: Wholesalers vs. Logistic Service Providers
2.2.1 Secondary Wholesalers
2.2.2 Direct-to-Pharmacy (DTP) Distribution is Becoming More Prevalent
2.2.3 Major Wholesalers: Distribution of a Large Number of Products to Generate High Profits
2.2.4 Distribution from Large to Small Wholesalers: A Lengthy Distribution Chain
2.2.5 Pharmacy Benefit Managers
2.3 Generative Revenue and Profit
2.3.1 Forward Buying to Avoid Price Increases
2.3.2 Fee-for-Service: A Clear Pricing Structure
2.3.2.1 Inventory Management Agreements
2.3.3 Discounts: Incentives for Prompt Payment or Bulk Purchases
2.3.4 Reimbursement and Wholesalers
2.3.5 Clawback: The Recovery of Reimbursement Costs by Governments
2.3.6 Parallel Trade: Different Attitudes in Europe and the US
3. The World Pharmaceutical Wholesale and Distribution Market: 2015-2026
3.1 The World Pharmaceutical Wholesale and Distribution Market in 2015, Restricted by Government Price Reductions and Generic Substitution
3.2 The Pharmaceutical Wholesale and Distribution Industry: World Market Forecast, 2015-2026
3.3 Branded and Generic Drugs: Revenue vs. Profit, 2015-2026
3.3.1 Branded and Generic Drugs: Revenue Generation, 2015
3.3.2 Branded Drugs: Revenue Forecast, 2015-2026
3.3.3 Generic Drugs: Revenue Forecast, 2015-2026
4. Pharmaceutical Wholesale and Distribution Industry: Leading National Markets, 2015-2026
4.1 The Leading National Markets: the US Dominates in 2015
4.2 The Future of the Leading National Markets: Will the US Continue to Dominate the Market?
4.3 The US Pharma Wholesale and Distribution Market
4.3.1 The Budget Control Act and its Effect on the US Wholesale and Distribution Industry
4.3.2 Legislation to Prevent Counterfeit Drugs Can Differ Between States
4.3.3 An Increase in Fee-For-Service Activity
4.3.4 Pharma Wholesale and Distribution Market in the US: Market Forecast, 2015-2026
4.4 The Leading European (EU5) Pharma Wholesale and Distribution Markets
4.4.1 The Difference Between the US and European Markets
4.4.2 State-Funded Healthcare and Reimbursement
4.4.3 EU5: Market Forecast, 2015-2026
4.4.4 Germany: Pharma Wholesale and Distribution Market, 2015
4.4.4.1 Healthcare Reform
4.4.4.2 Germany: Reform of AMNOG Pharmaceutical Rebate Law
4.4.4.3 Germany Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.4.5 France: Pharma Wholesale and Distribution Market, 2015
4.4.5.1 France: Social Security Finance Bill 2015
4.4.5.2 France: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.4.6 Italy: Pharma Wholesale and Distribution Market, 2015
4.4.6.1 Italy: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.4.7 Spain: Pharma Wholesale and Distribution Market, 2015
4.4.7.1 Spain: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.4.8 UK: Pharma Wholesale and Distribution Market, 2015
4.4.8.1 Price Cuts in the UK
4.4.8.2 UK: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.5 Japan: Pharma Wholesale and Distribution Market, 2015
4.5.1 Drug Pricing and Performing Fees in Japan
4.5.2 Japan: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.6 China: Pharma Wholesale and Distribution Market, 2015
4.6.1 China: Leading Pharma Wholesale and Distribution Companies, 2015
4.6.2 China: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.7 Brazil: Pharma and Wholesale Distribution Market, 2015
4.7.1 Drug Price Controls in Brazil
4.7.2 Brazil: Leading Pharma Wholesale and Distribution Companies, 2015
4.7.3 Brazil: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.8 India: Pharma Wholesale and Distribution Market, 2015
4.8.1 India: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.9 Russia: Pharma Wholesale and Distribution Market, 2015
4.9.1 Drug Pricing Controls in Russia
4.9.2 Market Trends in Russia
4.9.3 Russia: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.10 Conclusion
5. Leading Pharma Wholesalers and Distributors in 2016: Current and Future Performance
5.1 The Leading Pharma Wholesalers and Distribution Companies in 2015
5.2 Revenue vs. Profit
5.3 Leading Pharma Wholesale and Distribution Companies: Grouped Forecasts, 2015-2026
5.4 McKesson: The Oldest and Largest Healthcare Services Company in the US
5.4.1 McKesson: Historical Performance, 2010-2015
5.4.2 Future Strategies: Consummate Acquisitions to Complement Existing Business or Expand Businesses
5.4.3 McKesson: Revenue Forecast, 2015-2026
5.5 Cardinal Health: The World’s Third Largest Pharma Wholesaler
5.5.1 Cardinal Health: Historical Performance, 2010-2015
5.5.2 Will CVS Joint Venture and Acquisitions Stimulate Future Growth?
5.5.3 Cardinal Health: Revenue Forecast, 2015-2026
5.6 AmerisourceBergen: Second Largest Global Pharma Wholesaler and Distributor
5.6.1 AmerisourceBergen: Historical Performance, 2015
5.6.2 Will Contracts with Walgreens and Alliance Boots Drive Future Growth?
5.6.3 AmerisourceBergen: Revenue Forecast, 2015-2026
5.7 Walgreens Boots Alliance: The Largest Drugstore Chain in the US and Global Wholesale and Distribution Network
5.7.1 Walgreens Boots Alliance: Historical Performance, 2011-2015
5.7.2 Acquisitions and Future Strategies of Walgreens Boots Alliance
5.7.3 Walgreens Boots Alliance: Revenue Forecast, 2015-2026
5.8 MEDIPAL HOLDINGS CORPORATION: Japan’s Leading Pharmaceutical Wholesaler
5.8.1 MEDIPAL HOLDINGS CORPORATION: Historical Performance, 2011-2015
5.8.2 Future Strategies of MEDIPAL HOLDINGS CORPORATION: Revised Business Portfolio with Diverse Sources of Earnings
5.8.3 MEDIPAL HOLDINGS CORPORATION: Revenue Forecast, 2015-2026
5.9 Phoenix Group: Biggest European Wholesalers
5.9.1 The PHOENIX Group: Historical Performance, 2011-2015
5.9.2 Future Strategies of the PHOENIX Group: Selective Acquisition
5.9.3 The PHOENIX Group: Revenue Forecast, 2015-2026
5.10 SINOPHARM: The Leading Pharmaceutical Wholesaler and Distributor in China
5.10.1 SINOPHARM: Historical Performance, 2011-2015
5.10.2 Future Strategies of SINOPHARM: Provide Comprehensive Services and Wider Business Coverage
5.10.3 SINOPHARM: Revenue Forecast, 2015-2026
5.11 Alfresa Holdings: Second Largest Pharmaceutical Wholesaler and Distributor in Japan
5.11.1 Alfresa Holdings: Historical Performance, 2011-2015
5.11.2 Future Strategy of Alfresa Holdings: To Focus on Expanding Business Fields and Increasing Footprint
5.11.3 Alfresa Holdings: Revenue Forecast, 2015-2026
5.12 SUZUKEN CO., LTD: The First Nationwide Wholesaler of Japan
5.12.1 SUZUKEN CO. LTD: Historical Performance, 2011-2015
5.12.2 Future Strategies of SUZUKEN CO., LTD: Five Growth Initiatives and Special Focus on Diabetes Field
5.12.3 SUZUKEN CO., LTD: Revenue Forecast, 2015-2026
5.13 Shanghai Pharmaceuticals Holding: China’s Second Largest Wholesaler
5.13.1 Shanghai Pharmaceuticals Holding: Historical Performance, 2011-2015
5.13.2 Future Strategies of Shanghai Pharma: Expansion of Three Leading Regions in China
5.13.3 Shanghai Pharma: Revenue Forecast, 2015-2026
6. Qualitative Analysis of the Pharma Wholesale and Distribution Market
6.1 The Strengths and Weaknesses of the Pharma Wholesale and Distribution Market, 2016
6.1.1 The Insatiable Demand for Drugs: A Recession Proof Industry?
6.1.2 Wholesalers Do More than Deliver Drugs
6.1.2.1 Pre-Wholesaling: More Prevalent in Europe
6.1.2.2 Through Pre-Financing, Full-Line Wholesalers Finance the Entire Medicines Market
6.1.3 Large Companies Dominate the Market
6.1.4 Despite High Revenues, Profit Margins Are Low
6.1.5 Government-Induced Drug Price Pressures Restrict Profits
6.1.6 The Problem of Counterfeit Drugs
6.2 The Opportunities and Threats of the Pharma Wholesale and Distribution Market, 2015-2026
6.2.1 The Demand for Pharmaceuticals is Increasing
6.2.2 The Increasing Use of Specialty Drugs Will Drive Growth
6.2.3 The Increasing Use of Generic Drugs Will Limit Revenue, But Drive Profit Generation
6.2.4 The Promotion of Drug Therapy in the US
6.2.5 Globalisation: The Major National Markets are Dominated by Few Companies
6.2.6 Increased Adoption of the DTP Distribution Model
6.2.6.1 DTP in Europe: The First Place the Scheme Has Taken Hold
6.2.6.2 DTP in the UK Since 1991
6.2.6.3 DTP in Poland: The Second European Country To Adopt the DTP Model
6.2.6.4 Further Expansion of the DTP Model
6.2.7 The Threat of Healthcare Budget Cuts
6.2.7.1 Healthcare Budget Cuts in Germany
6.2.7.2 Healthcare Budget Cuts in France
6.2.7.3 Healthcare Budget Cuts in Italy
6.2.7.4 Healthcare Budget Cuts in Spain
6.2.7.5 Healthcare Budget Cuts in the UK
6.2.8 Do Large Pharmacy Chains Pose a Threat?
6.2.8.1 Case Study: Walmart and the $4 Prescription Scheme
6.2.8.2 Vertical Integration of Wholesalers: A Response to the Threat of Pharmacy Chains
6.2.9 Does the Diversion and Re-Importation of Medicines Pose a Threat to the Industry?
6.2.10 The Threat of Industry Consolidation
6.3 Social, Technological, Economical and Political Factors Influencing the Market, 2015-2026 (STEP Analysis)
6.3.1 Political Factor: The Impact of Recent Regulatory Changes in the EU
6.3.2 Political Factor: Combating Counterfeit Medicines
6.3.2.1 The US and E-Pedigree: Becoming Law in California
6.3.2.2 European Pedigree Legislation
6.3.2.3 Anti-Counterfeiting Strategies in Other Markets: The Chinese Government is Attempting to Address the Challenge
6.3.2.4 Serialisation for Wholesalers: Opportunity or a Challenge?
7. Research Interview
7.1 Interview with Mr Chris Frost, Sales Director of AAH Pharmaceuticals Ltd., (Celesio UK), Coventry
7.1.1 Current Status and Evolution of Pharma Wholesale and Distribution Market, UK
7.1.2 Driving Factors of the Pharma Wholesale and Distribution Market in the UK?
7.1.3 Future of the UK Pharma Wholesale and Distribution Market
7.1.4 Celesio UK Accounted for More than 60% of the Group’s Total Retail Pharmacy Business in 2013
7.1.5 The Outcome of McKesson’s Acquisition of Celesio AG
7.1.6 Prominent Business Segments of Celesio AG in the Future
8. Conclusions
8.1 The Future of the Pharma Wholesale and Distribution Market
8.2 The Leading National Pharma Wholesale and Distribution Markets
8.3 The Leading Companies in the Pharma Wholesale and Distribution Industry
8.4 Trends in the Pharma Wholesale and Distribution Industry
8.4.1 Generics Will Threaten Revenue
8.4.2 Manufacturers Will Deliver More Drugs Directly
8.4.3 There Will Be Greater Demand for Specialty Medicines
8.4.4 Consolidation Will Drive Growth
8.4.5 Anti-Counterfeiting Demands Will Add to Wholesalers’ Costs
【レポート販売概要】
■ タイトル:医薬品卸売・物流の世界市場予測2016-2026■ 英文:Pharma Wholesale and Distribution Market Forecasts 2016-2026
■ 発行日:2016年9月
■ 調査会社:visiongain
■ 商品コード:VGAIN61117
■ 調査対象地域:グローバル
- ヘルスケア情報システムの世界市場2015-2019About healthcare information system A healthcare information system is an integrated system designed for capturing, storing, managing, and transmitting information related to the health of individuals. This system helps end-users to make informative decisions. It collects data from healthcare facilities and analyzes these data to ensure their overall quality, relevance, and timeliness and converts …
- 医薬品パッケージングの世界市場2016-2026The global pharmaceutical packaging market is expected to expand, driven primarily by the Chinese, US, Japanese and European markets. These markets are highly competitive where local and international regulations play a relevant role. The pharmaceutical packaging market will also be driven by new pharmaceutical products, increasing demand for blister packaging, the growth in anti-counterfeiting an …
- ビッグデータ&ビジネス分析の世界市場:構成要素別(ソフトウェア&サービス)、展開モデル別(オンプレミス&クラウド)、分析ツール別(ダッシュボード&データ可視化、セルフサービスツール、データマイニング&ウェアハウジング、レポート、その他)、用途別(顧客分析、サプライチェーン分析、マーケティング分析、価格分析、空間分析、労働力分析、リスク&信用分析、輸送分析)、産業別(製造、BFSI、ヘルスケア、政府、エネルギー&ユーティリティ、輸送、小売&消費財、IT&通信、教育、その他)Big data analytics is the process of examining large set of data or varied set of data for uncovering useful information, which can help organizations make informed business decisions. In addition, it analyzes business data and information through continuous investigation and exploration of old business performance data to obtain conclusive insights for business planning. Furthermore, big data ana …
- 世界における農業用アジュバント(補助剤)市場The global agriculture adjuvants market is one of the segments of agrochemical market, which comes under a broad category of crop protection chemicals. Agriculture adjuvants market consists of activator adjuvants, which include surfactants, oils, ammonium fertilizers, and the other utility adjuvants that comprises of compatible agents, drift control agents, acidifiers/buffers, water conditioners, …
- 蚊よけ剤(虫よけ剤)の世界市場2015-2019About mosquito repellent Mosquito repellents, used to prevent mosquito bites, are available in the market as coils, vaporizers, sprays, mats, creams, and bands. According to WHO, rising global warming is an important factor leading to increase in the number of mosquitoes that carry diseases like malaria, yellow fever, and dengue. With more people taking preventive measures against mosquito-borne d …
- Penn Virginia Corporation:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Penn Virginia Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Penn Virginia Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essentia …
- 生物学的合理殺虫剤の世界市場分析:製品別(植物、半化学物質)、苗別(穀物・種子、果物・野菜)、セグメント予測The global biorationals market is expected to reach USD 2.75 billion by 2024, according to a new report by Grand View Research, Inc. Shifting consumer trend towards natural and organic crop stress management products has played a major role in promoting industry growth over the next eight years. Currently, biorational products are widely used in agriculture, structural pest control, forestry, publ …
- クラウドIAM(アイデンティティ及びアクセス管理)の世界市場About Cloud IAM IAM is a security solution that ensures the accessibility of resources to authorized individuals in a multi-technology environment. IAM solutions provide secure identity-based access to on-premises and cloud-based systems, applications, and information from any location. These solutions help enterprises secure application systems by permitting employee access with a single sign-on …
- 溶接消耗品の世界市場2017-2021About Welding Consumables Welding consumables broadly consist of filler metals and flux. These materials undergo melting to join two metals strongly and help to protect the molten weld from any form of atmospheric contaminants. Welding consumables are predominantly used in arc-welding and oxy-fuel welding technologies. Technavio’s analysts forecast the global welding consumables market to grow at …
- 世界航空産業におけるアクチュエーター市場分析と予測(2013-2018)The report covers in-depth analysis of the Actuator Systems market. It provides information about actuation systems used in the market with respect to geography, technology, and the current market scenario. It throws light on the current market trends, the drivers and restraints, the challenges faced, and the opportunities that will impact the growth of this market. It analyzes the actuator market …
- IGBT(パワー半導体素子)のグローバル市場(2014-2018)About IGBT An IGBT is a semiconductor component used in power electronic devices across several industries because it has high-power efficiency, high blocking voltage, and the ability to work on low power. An IGBT module is formed by arranging, in parallel, several discrete IGBTs in a single casing. These modules are used in industrial motors, railway traction, power supplies, renewable energy, an …
- 世界のデータセンター・インフラ管理市場動向(2012-2016)TechNavio's analysts forecast the Global Data Center Infrastructure Management market to grow at a CAGR of 47.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapid evolution of cloud computing. The Global Data Center Infrastructure Management market has also been witnessing the incorporation of advanced data center capacity management features …
- Red Mountain Resources Inc.:石油・ガスの開発・生産動向及びコスト分析– 2012Red Mountain Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Red Mountain Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essentia …
- 世界のトップ10セキュリティ技術市場“Rise in security breaches and incidents among the enterprises is expected to drive the growth of the security technologies market during the forecast period”The report titled The Top 10 security Technologies Market – Global Forecast to 2020/2021 expects that the market will grow at a significant rate between 2015/2016 and 2020/2021. This report covers Software-Defined Security, Application Securi …
- 小売産業におけるパーソナライゼーショントレンド(事例分析)Summary “Trends in Personalization in Retail” report, published by Conlumino, gives a snapshot of some of the current examples of personalization in retail and the issues that arise. Key Findings - Retailers are utilizing a host of platforms, including mobile and social media to engage customers and offer them a personalized shopping experience. - 3D printing is gaining traction as a means to offe …